Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-Cycloserine and Exposure Therapy for Combat-Related PTSD
NCT01352637Phase 3Completed
- Sponsor
- Weill Cornell Medicine
- Start
- May 2011
- Primary completion
- Sep 2018
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of d-cycloserine in post-traumatic stress disorder (PTSD), sponsored by Weill Cornell Medicine. Started May 2011; status: completed.
02
Drugs
d-cycloserine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT01352637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01352637.